Search Results - "Vaporciyan, AA"

Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery by Wang, Shu-lian, Liao, Zhongxing, Vaporciyan, Ara A, Tucker, Susan L, Liu, Helen, Wei, Xiong, Swisher, Stephen, Ajani, Jaffer A, Cox, James D, Komaki, Ritsuko

“…To assess the association of clinical and especially dosimetric factors with the incidence of postoperative pulmonary complications among esophageal cancer…”
Get more information

Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients by Vaporciyan, Ara A, Correa, Arlene M, Rice, David C, Roth, Jack A, Smythe, W.R, Swisher, Stephen G, Walsh, Garrett L, Putnam, Joe B

“…The purpose of this study was to identify risk factors associated with the onset of atrial fibrillation after thoracic surgery to allow more targeted…”
Get full text

2‐Fluoro‐2‐deoxy‐D‐glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma by Swisher, Stephen G., Erasmus, Jeremy, Maish, Mary, Correa, Arlene M., Macapinlac, Homer, Ajani, Jaffer A., Cox, James D., Komaki, Ritsuko R., Hong, David, Lee, Hoon K., Putnam, Joe B., Rice, David C., Smythe, W. Roy, Thai, Linh, Vaporciyan, Ara A., Walsh, Garrett L., Wu, Tsung‐Teh, Roth, Jack A.

“…BACKGROUND The current study was performed to assess the value of 2‐fluoro‐2‐deoxy‐d‐glucose positron emission tomography (FDG‐PET) in predicting the…”
Get full text

Hormone replacement therapy and lung cancer risk: A case-control analysis by SCHABATH, Matthew B, XIFENG WU, VASSILOPOULOU-SELLIN, Rena, VAPORCIYAN, Ara A, SPITZ, Margaret R

“…To date, there are few published data regarding the use of hormone replacement therapy (HRT) and lung cancer risk. Therefore, we analyzed data regarding HRT…”
Get full text

Utility of PET, CT, and EUS to Identify Pathologic Responders in Esophageal Cancer by Swisher, Stephen G., Maish, Mary, Erasmus, Jeremy J., Correa, Arlene M., Ajani, Jaffer A., Bresalier, Robert, Komaki, Ritsuko, Macapinlac, Homer, Munden, Reginald F., Putnam, Joe B., Rice, David, Smythe, W.Roy, Vaporciyan, Ara A., Walsh, Garrett L., Wu, Tsung T., Roth, Jack A.

“…This study evaluates the utility of positron emission tomography (PET), endoscopic ultrasonography (EUS), and computed tomographic (CT) scans to predict…”
Get full text

Intrathoracic leaks following esophagectomy are no longer associated with increased mortality by Martin, Linda W, Swisher, Stephen G, Hofstetter, Wayne, Correa, Arlene M, Mehran, Reza J, Rice, David C, Vaporciyan, Ara A, Walsh, Garrett L, Roth, Jack A

“…Assess outcomes following intrathoracic leaks after esophagectomy from 1970 to 2004 to evaluate the impact of evolving surgical and perioperative techniques on…”
Get full text

Treatment outcomes of resected esophageal cancer by Hofstetter, Wayne, Swisher, Stephen G, Correa, Arlene M, Hess, Kenneth, Putnam, Jr, Joe B, Ajani, Jaffer A, Dolormente, Marcelo, Francisco, Rhodette, Komaki, Ritsuko R, Lara, Axbal, Martin, Faye, Rice, David C, Sarabia, Arcenio J, Smythe, W Roy, Vaporciyan, Ara A, Walsh, Garrett L, Roth, Jack A

“…To assess the evolution of treatment and outcome for resected esophageal cancer at a single institution. Strategies for optimizing the treatment of resected…”
Get full text

Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications by Erasmus, Jeremy J., Truong, Mylene T., Smythe, W. Roy, Munden, Reginald F., Marom, Edith M., Rice, David C., Vaporciyan, Ara A., Walsh, Garrett L., Sabloff, Bradley S., Broemeling, Lyle D., Stevens, Craig W., Pisters, Katherine M., Podoloff, Donald A., Macapinlac, Homer A.

“…Integrated computed tomography-positron emission tomography imaging with coregistration of anatomic and functional imaging data may improve the accuracy of…”
Get full text

Preoperative chemotherapy prior to pulmonary metastasectomy in surgically resected primary colorectal carcinoma by Subbiah, Ishwaria M, Blackmon, Shanda H, Correa, Arlene M, Kee, Bryan, Vaporciyan, Ara A, Swisher, Stephen G, Eng, Cathy

“…The benefit of preoperative chemotherapy prior to pulmonary metastasectomy for patients with colorectal carcinoma (CRC) is unknown. Here, we identify outcomes…”
Get full text

Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT) by Swisher, Stephen G, Hofstetter, Wayne, Wu, Tsung T, Correa, Arlene M, Ajani, Jaffer A, Komaki, Ritsuko R, Chirieac, Lucian, Hunt, Kelly K, Liao, Zhongxing, Phan, Alexandria, Rice, David C, Vaporciyan, Ara A, Walsh, Garrett L, Roth, Jack A

“…To determine the impact of pathologic response following preoperative chemoradiation (CRT) on the AJCC esophageal cancer staging system. Increasing numbers of…”
Get full text

Induction of p53-regulated Genes and Tumor Regression in Lung Cancer Patients after Intratumoral Delivery of Adenoviral p53 (INGN 201) and Radiation Therapy by SWISHER, Stephen G, ROTH, Jack A, ATKINSON, N. Edward, CORREA, Arlene M, DOLORMENTE, Marcelo, DREILING, Linda, EL-NAGGAR, Adel K, FOSSELLA, Frank, FRANCISCO, Rhodette, GLISSON, Bonnie, GRAMMER, Susan, HERBST, Roy, KOMAKI, Ritsuko, HUARINGA, Armando, KEMP, Bonnie, KHURI, Fadlo R, KURIE, Jonathan M, ZHONGXIO LIAO, MCDONNELL, Timothy J, MORICE, Rudolfo, MORELLO, Frank, MUNDEN, Reginald, PAPADIMITRAKOPOULOU, Vassiliki, JIAN GU, PISTERS, Katherine M. W, PUTNAM, Joe B, SARABIA, Arcenio J, SHELTON, Thomas, STEVENS, Craig, SHIN, Daniel M, SMYTHE, William R, VAPORCIYAN, Ara A, WALSH, Garrett L, MIN YIN, LEE, J. Jack, HICKS, Marshall, RO, Jae Y, HONG, Waun K, MERRITT, James A, AHRAR, Kamaran

“…Purpose: We designed a prospective single arm Phase II study to evaluate the feasibility and mechanisms of apoptosis induction after Ad-p53 ( INGN 201 ) gene…”
Get full text

Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response by Rohatgi, Pooja, Swisher, Stephen G., Correa, Arlene M., Wu, Tsung‐T., Liao, Zhongxing, Komaki, Ritsuko, Walsh, Garrett L., Vaporciyan, Ara A., Rice, David C., Roth, Jack A., Ajani, Jaffer A.

“…BACKGROUND The purpose of the current study was to test the hypothesis that a lower clinical TNM stage is associated with a higher rate of pathologic complete…”
Get full text

Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy by Swisher, Stephen G., Wynn, Paula, Putnam, Joe B., Mosheim, Melinda B., Correa, Arlene M., Komaki, Ritsuko R., Ajani, Jaffer A., Smythe, W.Roy, Vaporciyan, Ara A., Roth, Jack A., Walsh, Garrett L.

“…Objectives: Some patients and oncologists choose to treat localized esophageal cancer with definitive chemotherapy and radiation therapy rather than surgery. A…”
Get full text

Visceral pleural invasion is not predictive of survival in lung cancer patients with smaller tumor size by David, E, Thall, PF, Kalhor, N, Hofstetter, WL, Rice, DC, Roth, JA, Swisher, SG, Walsh, GL, Vaporciyan, AA, Wei, C, Mehran, RJ

Get full text

Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters by Lee, Hoon K, Vaporciyan, Ara A, Cox, James D, Tucker, Susan L, Putnam, Jr, Joe B, Ajani, Jaffer A, Liao, Zhongxing, Swisher, Stephen G, Roth, Jack A, Smythe, W Roy, Walsh, Garrett L, Mohan, Radhe, Liu, Hui H, Mooring, Deidre, Komaki, Ritsuko

“…To clarify the relationship between the percentage of lung receiving low radiation doses with concurrent chemotherapy and the occurrence of postoperative…”
Get more information

Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma by Ahamad, Anesa, Stevens, Craig W, Smythe, W Roy, Vaporciyan, Ara A, Komaki, Ritsuko, Kelly, Jason F, Liao, Zhongxing, Starkschall, George, Forster, Kenneth M

“…Malignant pleural mesothelioma (MPM) causes symptoms and death mainly due to local progression, even after combined modality treatment. Poor local control…”
Get more information

Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome by Onn, Amir, Choe, Du Hwan, Herbst, Roy S, Correa, Arlene M, Munden, Reginald F, Truong, Mylene T, Vaporciyan, Ara A, Isobe, Takeshi, Gilcrease, Michael Z, Marom, Edith M

“…To retrospectively identify radiographic characteristics of stage I non-small cell lung cancer (NSCLC) that may correlate with epidermal growth factor receptor…”
Get more information

Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy by Rohatgi, Pooja R., Swisher, Stephen G., Correa, Arlene M., Wu, Tsung T., Liao, Zhongxing, Komaki, Ritsuko, Walsh, Garrett L., Vaporciyan, Ara A., Rice, David C., Bresalier, Robert S., Roth, Jack A., Ajani, Jaffer A.

“…BACKGROUND The current study tested the hypothesis that the clinical outcome of patients with localized esophageal carcinoma after preoperative…”
Get full text

Extended Surgical Staging for Potentially Resectable Malignant Pleural Mesothelioma by Rice, David C., Erasmus, Jeremy J., Stevens, Craig W., Vaporciyan, Ara A., Wu, Judy S., Tsao, Anne S., Walsh, Garrett L., Swisher, Stephen G., Hofstetter, Wayne L., Ordonez, Nelson G., Smythe, W. Roy

“…Extrapleural pneumonectomy for malignant pleural mesothelioma (MPM) is a high-risk procedure, and patients require careful preoperative staging to exclude…”
Get full text

Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction by Ascioti, Anthony J., Hofstetter, Wayne L., Miller, Michael J., Rice, David C., Swisher, Stephen G., Vaporciyan, Ara A., Roth, Jack A., Putnam, J.B., Smythe, W. Roy, Feig, Barry W., Mansfield, Paul F., Pisters, Peter W.T., Torres, Marla T., Walsh, Garrett L.

“…Many patients with cancer have limited esophageal reconstruction options when the stomach is unavailable as a replacement conduit or when long-segment…”
Get full text